Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Health and Human Services Food and Drug Administration [Docket No. FDA-2010-N-0425]
 AGENCY: Food and Drug Administration, HHS.
 ACTION: Notice.
 SUMMARY: The Food and Drug Administration (FDA) is withdrawing approval of four new animal drug applications (NADAs). In a final rule published elsewhere in this issue of the 
                        **Federal Register**
                        , FDA is amending the regulations to remove portions reflecting approval of these NADAs.
 DATES: Withdrawal of approval is effective September 24, 2010.
 FOR FURTHER INFORMATION CONTACT: John Bartkowiak, Center for Veterinary Medicine (HFV-212), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-276-9079, email: 
                        *john.bartkowiak@fda.hhs.gov*.


SUPPLEMENTARY INFORMATION: John J. Ferrante, 11 Fairway Lane, Trumbull, CT 06611; International Nutrition, Inc., 7706 “I” Plaza, Omaha, NE 68127; and Feed Service Co., Inc., 303 Lundin Blvd., P.O. Box 698, Mankato, MN 56001 have requested that FDA withdraw approval of the four NADAs listed in table 1 because they are no longer manufactured or marketed: **Table**
                         1.
Sponsor
NADA Number Product (Established Name of Drug)
21 CFR Cite (Sponsor's Drug Labeler Code)John J. Ferrante, 11 Fairway Lane, Trumbull, CT 06611
NADA 65-137 AMPHICOL-V Capsules (chloramphenicol)
§ 520.390b (058034)International Nutrition, Inc., 7706 “I” Plaza, Omaha, NE 68127
NADA 121-337 INI Swine Ban-Wormer B-9.6 BA. (pyrantel tartrate)
§ 558.485 (043733)International Nutrition, Inc., 7706 “I” Plaza, Omaha, NE 68127
NADA 132-923 LINCO 8/LINCO 20 (lincomycin)
§ 558.325 (043733)Feed Service Co., Inc., 303 Lundin Blvd., P.O. Box 698, Mankato, MN 56001
NADA 138-342 TYLAN 5 Sulfa-G Premix (tylosin and sulfamethazine)
§ 558.630 (030841)
 Therefore, under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, and in accordance with § 514.116 
                    *Notice of withdrawal of approval of application*
                     (21 CFR 514.116), notice is given that approval of NADAs 65-137, 121-337, 132-923, and 138-342, and all supplements and amendments thereto, is hereby withdrawn, effective September 24, 2010. In a final rule published elsewhere in this issue of the 
                    **Federal Register**
                    , FDA is amending the animal drug regulations to reflect the withdrawal of approval of these NADAs. Dated: September 1, 2010. Bernadette Dunham, Director, Center for Veterinary Medicine.


[FR Doc. 2010-22809 Filed 9-13-10; 8:45 am] BILLING CODE 4160-01-S